Kardigan,
KARDPharmaceuticals · NASDAQ · IPO June 18, 2026
01
Company Overview
Kardigan, is filing to list on NASDAQ Global. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Kardigan, is going public on NASDAQ Global on 2026-06-18. Offering 25,000,000 shares.
Recent headlines
- Kardigan surges in Nasdaq debut after upsized $400 million IPOreuters.com
Kardigan's shares rose 31% above their initial public offering price on Thursday after the heart drug developer raised $400 million in an ...
- Kardigan (KARD) Upsizes IPO & Prices it at $16 – Top of Rangeiposcoop.com
Kardigan's stock ended Thursday's session at $22.00 – up $6.00 from its IPO price for a first-day gain of 37.5 percent – in its NASDAQ debut on ...
- Kardigan (KARD) Stock Price & Overviewstockanalysis.com
Kardigan rises in Nasdaq debut after upsized $400 million IPO. Kardigan's shares rose 1.6% in their Nasdaq debut on Thursday, after the heart drug ...
- Kardigan targets $1.4 billion valuation in U.S. IPO - Yahoo Financefinance.yahoo.com
The Princeton, N.J., biotech plans to raise up to $373.3 million by selling 23.3 million shares priced between $14 and $16 each.
- Kardigan extends biotech's streak of big IPOs with $400M haulbiopharmadive.com
Kardigan is now the fourth drug startup this year to raise at least $400 million in IPO proceeds, a total rarely hit since 2021, according to ...
02
AI Analysis
Possible growth narrative
Sits adjacent to Biotech & Healthcare — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- June 18, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Pharmaceuticals
- Valuation
- $400.0M raise
- Headquarters
- US
- Attention score
- 61 / 100
- Ticker
- KARD